Follow The Filings

AXSM position history

The shares of Axsome Therapeutics (AXSM) that TORRAY INVESTMENT PARTNERS LLC reported in each quarter’s 13F.

Equity, COM

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1: 16,897 shares, $1.7M, 0.25% of portfolio, New
  2. 2024 Q2: 11,747 shares, $946K, 0.14% of portfolio, Reduce −30.5%
  3. 2024 Q3: 11,823 shares, $1.1M, 0.15% of portfolio, Add +0.6%
  4. 2024 Q4: 17,174 shares, $1.5M, 0.21% of portfolio, Add +45.3%
  5. 2025 Q1: 17,116 shares, $2M, 0.30% of portfolio, Reduce −0.3%
  6. 2025 Q2: 17,065 shares, $1.8M, 0.26% of portfolio, Reduce −0.3%
  7. 2025 Q3: 17,419 shares, $2.1M, 0.29% of portfolio, Add +2.1%
  8. 2025 Q4: 14,794 shares, $2.7M, 0.39% of portfolio, Reduce −15.1%
  9. 2026 Q1: 14,774 shares, $2.5M, 0.37% of portfolio, Reduce −0.1%
  10. 2026 Q2: 14,928 shares, $3.7M, 0.49% of portfolio, Add +1.0%
  11. 2026 Q3: 14,887 shares, $2.7M, 0.36% of portfolio, Reduce −0.3%
Holdings date Value % of holdings Shares Filing date All 13F holders